An anti-virulence drug targeting the evolvability protein Mfd protects against infections with antimicrobial resistant ESKAPE pathogens
2025 · Nature Communications · 3 citations
https://doi.org/10.1038/s41467-025-58282-8
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
56
Citations
2
h-index
1
i10-index
Lucie Lebreuilly is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Bacterial Genetics and Biotechnology & Gut microbiota and health & Antibiotic Resistance in Bacteria. The author has an h-index of 2, co-authored 3 publications.
Click to start Chat